| Biotechnology Industry | Healthcare Sector | Timothy George Dixon CEO | OTC PINK Exchange | 883378101 CUSIP |
| US Country | 3 Employees | - Last Dividend | - Last Split | - IPO Date |
Therapeutic Solutions International, Inc. is a company dedicated to the development of innovative treatments aimed at modulating the immune system to target specific diseases. Since its establishment in 2007 and based in Elk City, Idaho, the company has been focusing on creating a wide array of immune-modulatory agents. These are designed to tackle cancers, schizophrenia, suicidal ideation, traumatic brain injury (TBI), lung pathologies, and general health maintenance. Through its commitment to research and development, Therapeutic Solutions International aims to pioneer groundbreaking therapies that can significantly enhance patient health and recovery.